Revenue Growth
Consolidated net sales increased 27% year‑over‑year to $50.2 million, driven by strength in international medical exports and Canadian branded sales.
Strong Adjusted EBITDA Expansion
Consolidated adjusted EBITDA from continuing operations rose 118% year‑over‑year to $9.9 million, lifting adjusted EBITDA margin to 20% from 11.4% in the prior‑year quarter.
Return to Profitability
Consolidated net income from continuing operations was $2.7 million ($0.03 per share) versus a net loss of $2.1 million in Q1 last year, marking the fourth consecutive quarter of positive net income.
Record International Exports
International export sales nearly tripled year‑over‑year, increasing 171% to a record of nearly $15 million and growing 60% sequentially, with Germany a primary driver.
Improved Gross Margins
Cannabis gross margin rose to 43% from 39% a year ago, staying above the company's 30%–40% target range, supported by higher international export mix and Netherlands contribution.
Cannabis Segment Profitability
Cannabis segment adjusted EBITDA improved 48% to $10.2 million (20.5% margin) versus $6.9 million a year ago, reflecting favorable product mix and international sales.
Capacity and Facility Milestones
Completed major EU‑GMP production upgrades in British Columbia (company believes it now operates the world's largest EU‑GMP certified cannabis facility). Began planting at Delta 2 expansion (adds ~40 MT annual capacity at full ramp; ~15 MT incremental this year). Groningen Phase 2 construction completed; awaiting final certification to begin operations.
Market Share and Brand Momentum in Canada
Maintained a top‑5 overall share in Canada's adult‑use market and #1 share in dried flower. Pure Sunfarms achieved 15 consecutive months of flower market share gains; branded sales up ~5% year‑over‑year.
Balance Sheet and Capital Allocation
Ended Q1 with approximately $56 million cash (including $5 million restricted) and a stated net cash position of $20 million. Total debt $36 million. Completed share repurchases of over 2 million shares at $6.4 million in Q1 (Board‑approved buyback subsequently completed). Amended and extended Farm Credit Canada loan with improved rate and maturity to Feb 2031.